BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/29/2025 10:40:05 AM | Browse: 27 | Download: 0
Publication Name World Journal of Experimental Medicine
Manuscript ID 108984
Country Russia
Category Oncology
Manuscript Type Observational Study
Article Title Concordance of programmed death-ligand 1 expression assessments determined via two immunohistochemical tests and the polymerase chain reaction method
Manuscript Source Invited Manuscript
All Author List Marina A Senchukova, Natalia V Saidler, Evgeniya Yu Zubareva, Alexander B Prokofiev and Dmitry G Tagabilev
Funding Agency and Grant Number
Funding Agency Grant Number
Russian Science Foundation No. 23-25-00183
Corresponding Author Marina A Senchukova, MD, PhD, Professor, Scientific and Clinical Center No. 3, Petrovsky National Research Centre of Surgery, Oktyabrsky Prospekt 3, Moscow 108840, Troitsk, Russia. masenchukova@yandex.com
Key Words Breast cancer; Cohen kappa index; Negative percentage agreement; Positive percentage agreement; Programmed death-ligand 1; Programmed cell death protein 1 ligand 1
Core Tip We determined the expression of programmed cell death ligand 1 in immune cells using immunohistochemistry with antibodies against programmed cell death protein 1 ligand 1 (PDCD1 LG1) and SP142 and polymerase chain reaction (PCR) and then examined the agreement between the results of three assays in patients with breast cancer (BC). All three tests were positively correlated with estrogen receptor-negative status, human epidermal growth factor receptor-2-positive (HER2+) status, and luminal B HER+, nonluminal HER+, and triple-negative BCs. Cohen's kappa index was 0.385 for PDCD1 LG1 and SP142 and 0.389 for SP142 and programmed death-ligand 1 (PCR), which is considered moderate agreement between the markers.
Citation <p>Senchukova MA, Saidler NV, Zubareva EY, Prokofiev AB, Tagabilev DG. Concordance of programmed death-ligand 1 expression assessments determined via two immunohistochemical tests and the polymerase chain reaction method. <i>World J Exp Med</i> 2025; 15(3): 108984</p>
Received
2025-04-27 15:35
Peer-Review Started
2025-05-04 01:31
To Make the First Decision
Return for Revision
2025-05-14 03:21
Revised
2025-05-21 09:33
Second Decision
2025-07-28 02:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-07-29 10:40
Articles in Press
2025-07-29 10:40
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-08-01 05:36
ISSN 2220-315x (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com